(Q40317281)

19 September 2017

title

Characterization of the antiviral effects of interferon-alpha against a SARS-like coronoavirus infection in vitro (English)

1 reference

19 September 2017

0 references

1 reference

4

Eleanor N Fish

1 reference

19 September 2017

Joanna Zorzitto

1

1 reference

19 September 2017

Carole L Galligan

series ordinal

2

1 reference

19 September 2017

Joanna J M Ueng

series ordinal

3

1 reference

19 September 2017

language of work or name

1 reference

1 February 2006

1 reference

19 September 2017

1 reference

19 September 2017

volume

16

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

220-229

1 reference

Characterization of a novel coronavirus associated with severe acute respiratory syndrome

19 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Identification of severe acute respiratory syndrome in Canada

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Review: IFN-alpha/beta receptor interactions to biologic outcomes: understanding the circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Antiviral actions of interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The virus battles: IFN induction of the antiviral state and mechanisms of viral evasion

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferons alpha and beta as immune regulators--a new look

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Therapeutic advances in the management of hepatitis B and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Intranasal interferon as protection against experimental respiratory coronavirus infection in volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The efficacy and tolerance of intranasal interferons: studies at the Common Cold Unit

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Comparative susceptibility of respiratory viruses to recombinant interferons-alpha 2b and -beta

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Glycyrrhizin, an active component of liquorice roots, and replication of SARS-associated coronavirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Severe acute respiratory syndrome-related coronavirus is inhibited by interferon- alpha

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Potent inhibition of SARS-associated coronavirus (SCOV) infection and replication by type I interferons (IFN-alpha/beta) but not by type II interferon (IFN-gamma).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferon-beta 1a and SARS coronavirus replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferon-beta and interferon-gamma synergistically inhibit the replication of severe acute respiratory syndrome-associated coronavirus (SARS-CoV).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Pegylated interferon-alpha protects type 1 pneumocytes against SARS coronavirus infection in macaques

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The biologic activity and molecular characterization of a novel synthetic interferon-alpha species, consensus interferon

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferon alfacon-1: a review of its pharmacology and therapeutic efficacy in the treatment of chronic hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferon alfacon-1 plus corticosteroids in severe acute respiratory syndrome: a preliminary study

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferons and their actions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

How cells respond to interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Activation of the p38 mitogen-activated protein kinase by type I interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Activation of a CrkL-stat5 signaling complex by type I interferons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Protein kinase C-delta (PKC-delta ) is activated by type I interferons and mediates phosphorylation of Stat1 on serine 727.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Mechanisms of type-I- and type-II-interferon-mediated signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Pathogenesis of experimental viral hepatitis (second of two parts).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Murine hepatitis virus--a model for virus-induced CNS demyelination.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Unique and conserved features of genome and proteome of SARS-coronavirus, an early split-off from the coronavirus group 2 lineage

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

SARS--beginning to understand a new virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The glycosylation status of the murine hepatitis coronavirus M protein affects the interferogenic capacity of the virus in vitro and its ability to replicate in the liver but not the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Protective effects of murine recombinant interferon-beta administered by intravenous, intramuscular or subcutaneous route on mouse hepatitis virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

RNase L-independent specific 28S rRNA cleavage in murine coronavirus-infected cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The antiviral effects of the interferons and their inhibition

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Constitutive activation of a slowly migrating isoform of Stat3 in mycosis fungoides: tyrphostin AG490 inhibits Stat3 activation and growth of mycosis fungoides tumor cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Involvement of p38 signaling pathway in interferon-alpha-mediated antiviral activity toward hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

p38 MAP kinase is required for STAT1 serine phosphorylation and transcriptional activation induced by interferons

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The p38 MAPK pathway mediates the growth inhibitory effects of interferon-alpha in BCR-ABL-expressing cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Effect of deficiency of the double-stranded RNA-dependent protein kinase, PKR, on antiviral resistance in the presence or absence of ribonuclease L: HSV-1 replication is particularly sensitive to deficiency of the major IFN-mediated enzymes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Interferon-alpha induction through Toll-like receptors involves a direct interaction of IRF7 with MyD88 and TRAF6

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Induction and regulation of IFNs during viral infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Dual role of alpha-defensin-1 in anti-HIV-1 innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Contribution of human alpha-defensin 1, 2, and 3 to the anti-HIV-1 activity of CD8 antiviral factor.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Regulation of interferon-induced protein kinase PKR: modulation of P58IPK inhibitory function by a novel protein, P52rIPK

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Viral interactions with the nuclear transport machinery: discovering and disrupting pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

A DEAD box protein facilitates HIV-1 replication as a cellular co-factor of Rev.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Alterations in the expression of DEAD-box and other RNA binding proteins during HIV-1 replication

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Transcriptional activation of alpha/beta interferon genes: interference by nonsegmented negative-strand RNA viruses

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Inhibition of Beta interferon induction by severe acute respiratory syndrome coronavirus suggests a two-step model for activation of interferon regulatory factor 3.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

A comprehensive view of regulation of gene expression by double-stranded RNA-mediated cell signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Global effect of PEG-IFN-alpha and ribavirin on gene expression in PBMC in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

The interaction of interferon-α and -γ: Regulation of (2–5)A synthetase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.CR.7310030

Prevention of experimental coronavirus colds with intranasal alpha-2b interferon

21 January 2018

1 reference

12 December 2020

Hepatitis C: therapeutic perspectives

1 reference

12 December 2020

Interferon alpha induces rapid tyrosine phosphorylation of the vav proto-oncogene product in hematopoietic cells.

1 reference

12 December 2020

Enhanced Growth of a Murine Coronavirus in Transformed Mouse Cells

1 reference

12 December 2020

The organ tropism of mouse hepatitis virus A59 in mice is dependent on dose and route of inoculation

1 reference

12 December 2020

Activation of the phosphatidylinositol 3-kinase serine kinase by IFN-alpha

1 reference

12 December 2020

Increased sensitivity of SARS-coronavirus to a combination of human type I and type II interferons.

1 reference

12 December 2020

Separation of antiviral activity of human interferon from cell growth inhibitory effect

1 reference

12 December 2020

Identifiers

DOI

10.1038/SJ.CR.7310030

1 reference

Dimensions Publication ID

19 September 2017

1020705557

0 references

PMC publication ID

7091892

0 references

1 reference